Skip to main content
2023 BMES Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Carmen Martin Alonso (she/her/hers)

PhD candidate
Massachussetts Institute of Technology / Harvard University
Cambridge, Massachusetts, United States

Carmen Martin Alonso is a 5th year PhD candidate in Medical Engineering and Medical Physics in the Health Sciences and Technology program of MIT and Harvard Medical School. Originally from Spain, Carmen completed her MEng in Biomedical Engineering at Imperial College London and then moved to Cambridge, MA to pursue her PhD in the Laboratory of Prof. Sangeeta Bhatia. Over the last two decades, circulating tumor DNA (ctDNA) that provides clinically-actionable information on tumors deep within the body through the convenience of a blood draw, has emerged as a promising strategy to overcome the limitations of traditional biopsies. Yet, the utility of ctDNA testing remains fundamentally limited by virtue that most cfDNA is rapidly cleared from circulation, yielding little material for detection in blood. To address this major bottleneck in liquid biopsy, Carmen has developed first-in-class ctDNA contrast agents that boost the recovery of ctDNA molecules from a blood draw to increase the sensitivity of tests for cancer detection.

Presentation(s):

Email Carmen